InsiderClue
Insiders · Profile

ASELAGE STEVE

Director at BIOCRYST PHARMACEUTICALS · Director at Travere Therapeutics · EVP, Chief Business Officer at BIOMARIN PHARMACEUTICAL. Filing since 31 Oct 2006. CIK 0001221599

BCRX BIOCRYST PHARMACEUTICALS INC Director · 4 trades TVTX Travere Therapeutics, Inc. Director · 41 trades BMRN BIOMARIN PHARMACEUTICAL INC EVP, Chief Business Officer · 30 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BCRX BIOCRYST PHARMACEUTICALS INC
24 May 2024
Director
Bought
2,500
$16.00K
opened
TVTX Travere Therapeutics, Inc.
11 May 2022
Director
Sold, plan not stated
2,575
$56.46K
1.7%
TVTX Travere Therapeutics, Inc.
16 Nov 2021
Director
Sold, plan not stated
31,800
$934.60K
17.5%
TVTX Travere Therapeutics, Inc.
5 Nov 2021
Director
Sold, plan not stated
10,000
$262.30K
5.8%
TVTX Travere Therapeutics, Inc.
2 Nov 2021
Director
Sold, plan not stated
3,500
$105.00K
15.2%
TVTX Travere Therapeutics, Inc.
1 Nov 2021
Director
Sold, plan not stated
5,000
$147.40K
17.9%
TVTX Travere Therapeutics, Inc.
7 Oct 2021
Director
Sold, plan not stated
60,000
$1.57M
24.0%
TVTX Travere Therapeutics, Inc.
11 May 2021
Director
Sold, plan not stated
2,146
$42.02K
1.1%
TVTX Travere Therapeutics, Inc.
16 Apr 2021
Director
Sold, plan not stated
10,000
$262.30K
5.0%
TVTX Travere Therapeutics, Inc.
17 Mar 2021
Director
Sold, plan not stated
17,727
$486.46K
8.6%
TVTX Travere Therapeutics, Inc.
2 Feb 2021
Director
Sold, plan not stated
25,000
$768.75K
11.3%
TVTX Travere Therapeutics, Inc.
15 Dec 2020
Director
Sold, plan not stated
5,549
$144.38K
2.7%
TVTX Travere Therapeutics, Inc.
2 Dec 2020
Director
Sold, plan not stated
7,891
$184.85K
3.8%
TVTX Travere Therapeutics, Inc.
6 Nov 2020
Director
Sold, plan not stated
20,625
$474.38K
8.8%
TVTX Travere Therapeutics, Inc.
5 Nov 2020
Director
Sold, plan not stated
2,500
$53.15K
1.1%
TVTX Travere Therapeutics, Inc.
5 Aug 2020
Director
Sold, plan not stated
2,500
$49.20K
1.0%
TVTX Travere Therapeutics, Inc.
25 Jun 2020
Director
Sold, plan not stated
10,000
$200.00K
4.0%
TVTX Travere Therapeutics, Inc.
14 May 2020
Director
Sold, plan not stated
3,062
$46.21K
1.2%
TVTX Travere Therapeutics, Inc.
13 May 2020
Director
Sold, plan not stated
4,063
$66.67K
1.6%
TVTX Travere Therapeutics, Inc.
12 May 2020
Director
Sold, plan not stated
1,000
$17.16K
0.4%
TVTX Travere Therapeutics, Inc.
5 May 2020
Director
Sold, plan not stated
2,500
$39.70K
1.0%
TVTX Travere Therapeutics, Inc.
5 Mar 2020
Director
Sold, plan not stated
4,359
$66.94K
1.7%
TVTX Travere Therapeutics, Inc.
5 Feb 2020
Director
Sold, plan not stated
2,500
$41.55K
1.0%
TVTX Travere Therapeutics, Inc.
29 Nov 2019
Director
Sold, plan not stated
5,000
$69.55K
2.0%
BCRX BIOCRYST PHARMACEUTICALS INC
18 Nov 2019
Director
Bought
15,000
$21.75K
225%
BCRX BIOCRYST PHARMACEUTICALS INC
22 May 2019
Director
Bought
3,000
$10.71K
150%
TVTX Travere Therapeutics, Inc.
15 May 2019
Director
Sold, plan not stated
1,838
$32.75K
0.7%
TVTX Travere Therapeutics, Inc.
14 May 2019
Director
Sold, plan not stated
1,838
$32.70K
0.7%
BCRX BIOCRYST PHARMACEUTICALS INC
12 Mar 2019
Director
Bought
2,000
$16.60K
opened
TVTX Travere Therapeutics, Inc.
12 Feb 2019
Chief Executive Officer
Sold, plan not stated
1,065
$22.90K
0.4%
TVTX Travere Therapeutics, Inc.
11 Feb 2019
Chief Executive Officer
Sold, plan not stated
1,065
$22.77K
0.4%
TVTX Travere Therapeutics, Inc.
21 Dec 2018
Chief Executive Officer
Sold, plan not stated
6,188
$134.83K
2.3%
TVTX Travere Therapeutics, Inc.
20 Dec 2018
Chief Executive Officer
Sold, plan not stated
6,188
$135.96K
2.3%
TVTX Travere Therapeutics, Inc.
7 Dec 2018
Chief Executive Officer
Sold, plan not stated
10
$240.37
0.0%
TVTX Travere Therapeutics, Inc.
15 Nov 2018
Chief Executive Officer
Sold, plan not stated
5,550
$134.97K
2.1%
TVTX Travere Therapeutics, Inc.
14 Nov 2018
Chief Executive Officer
Sold, plan not stated
5,550
$131.73K
2.1%
TVTX Travere Therapeutics, Inc.
31 Aug 2018
Chief Executive Officer
Sold, plan not stated
12,000
$384.00K
4.7%
TVTX Travere Therapeutics, Inc.
14 Jun 2017
Chief Executive Officer
Sold, plan not stated
5,000
$89.25K
2.0%
TVTX Travere Therapeutics, Inc.
22 Nov 2016
Chief Executive Officer
Sold, plan not stated
3,200
$68.16K
1.3%
TVTX Travere Therapeutics, Inc.
21 Nov 2016
Chief Executive Officer
Sold, plan not stated
5,000
$105.00K
2.0%
TVTX Travere Therapeutics, Inc.
10 Nov 2015
Chief Executive Officer
Sold, plan not stated
30,000
$561.60K
8.9%
TVTX Travere Therapeutics, Inc.
9 Nov 2015
Chief Executive Officer
Sold, plan not stated
30,000
$563.10K
8.1%
TVTX Travere Therapeutics, Inc.
21 Nov 2014
Chief Executive Officer
Bought
8,700
$73.95K
2.4%
TVTX Travere Therapeutics, Inc.
20 Nov 2014
Chief Executive Officer
Bought
1,300
$10.66K
0.4%
TVTX Travere Therapeutics, Inc.
15 Aug 2013
Director
Bought
556
$2.50K
0.2%
BMRN BIOMARIN PHARMACEUTICAL INC
2 Jul 2012
EVP, Chief Business Officer
Sold, plan not stated
95,345
$3.81M
61.8%
BMRN BIOMARIN PHARMACEUTICAL INC
15 May 2012
EVP, Chief Business Officer
Sold, plan not stated
10,000
$386.37K
14.5%
BMRN BIOMARIN PHARMACEUTICAL INC
11 May 2012
EVP, Chief Business Officer
Sold, plan not stated
26,160
$989.35K
30.7%
BMRN BIOMARIN PHARMACEUTICAL INC
28 Oct 2011
EVP, Chief Business Officer
Sold, plan not stated
16,875
$590.63K
26.6%
BMRN BIOMARIN PHARMACEUTICAL INC
26 May 2011
EVP, Chief Business Officer
Sold, plan not stated
40,512
$1.09M
47.9%
BMRN BIOMARIN PHARMACEUTICAL INC
25 May 2011
EVP, Chief Business Officer
Sold, plan not stated
9,177
$247.78K
17.3%
BMRN BIOMARIN PHARMACEUTICAL INC
3 May 2011
EVP, Chief Business Officer
Sold, plan not stated
10,311
$279.90K
24.7%
BMRN BIOMARIN PHARMACEUTICAL INC
18 Nov 2010
EVP, Chief Business Officer
Sold, plan not stated
31,375
$811.55K
51.2%
BMRN BIOMARIN PHARMACEUTICAL INC
17 Nov 2010
EVP, Chief Business Officer
Bought
8,000
$206.00K
36.6%
BMRN BIOMARIN PHARMACEUTICAL INC
17 Nov 2010
EVP, Chief Business Officer
Sold, plan not stated
500
$12.90K
0.8%
BMRN BIOMARIN PHARMACEUTICAL INC
8 Sep 2010
EVP, Chief Business Officer
Sold, plan not stated
35,000
$770.00K
48.2%
BMRN BIOMARIN PHARMACEUTICAL INC
8 Mar 2010
EVP, Chief Business Officer
Sold, plan not stated
24,090
$532.53K
54.8%
BMRN BIOMARIN PHARMACEUTICAL INC
5 Mar 2010
EVP, Chief Business Officer
Sold, plan not stated
6,416
$140.83K
12.7%
BMRN BIOMARIN PHARMACEUTICAL INC
4 Mar 2010
EVP, Chief Business Officer
Sold, plan not stated
5,000
$107.50K
9.0%
BMRN BIOMARIN PHARMACEUTICAL INC
3 Mar 2010
EVP, Chief Business Officer
Sold, plan not stated
10,000
$210.00K
24.2%
BMRN BIOMARIN PHARMACEUTICAL INC
2 Mar 2010
EVP, Chief Business Officer
Sold, plan not stated
10,000
$210.00K
19.5%
BMRN BIOMARIN PHARMACEUTICAL INC
6 May 2008
SVP, Global Commercial Dev.
Sold, plan not stated
16,200
$611.55K
36.1%
BMRN BIOMARIN PHARMACEUTICAL INC
2 May 2008
SVP, Global Commercial Dev.
Sold, plan not stated
3,800
$143.45K
7.8%
BMRN BIOMARIN PHARMACEUTICAL INC
30 Apr 2008
SVP, Global Commercial Dev.
Bought
1,526
$15.82K
4.8%
BMRN BIOMARIN PHARMACEUTICAL INC
1 Apr 2008
SVP, Global Commercial Dev
Sold, plan not stated
805
$29.02K
2.5%
BMRN BIOMARIN PHARMACEUTICAL INC
3 Mar 2008
SVP, Global Commercial Dev
Sold, plan not stated
40,000
$1.52M
55.5%
BMRN BIOMARIN PHARMACEUTICAL INC
2 Jan 2008
SVP, Global Commercial Dev
Sold, plan not stated
5,000
$180.40K
41.5%
BMRN BIOMARIN PHARMACEUTICAL INC
31 Oct 2007
SVP, Global Commercial Dev
Bought
2,139
$14.80K
43.7%
BMRN BIOMARIN PHARMACEUTICAL INC
1 Oct 2007
SVP, Global Commercial Dev
Sold, plan not stated
5,000
$125.47K
50.5%
BMRN BIOMARIN PHARMACEUTICAL INC
14 Sep 2007
SVP, Global Commercial Dev.
Sold, plan not stated
10,000
$224.00K
67.1%
BMRN BIOMARIN PHARMACEUTICAL INC
10 Aug 2007
SVP, Global Commercial Dev
Sold, plan not stated
20,000
$405.39K
80.3%
BMRN BIOMARIN PHARMACEUTICAL INC
30 Apr 2007
SVP, Global Commercial Dev
Bought
2,066
$14.29K
73.0%
BMRN BIOMARIN PHARMACEUTICAL INC
14 Feb 2007
SVP, Global Commercial Ops
Sold, plan not stated
15,000
$300.00K
84.1%
BMRN BIOMARIN PHARMACEUTICAL INC
29 Nov 2006
SVP, Global Commercial Ops
Sold, plan not stated
5,000
$86.15K
63.9%
BMRN BIOMARIN PHARMACEUTICAL INC
31 Oct 2006
SVP, Global Commercial Ops
Bought
1,870
$12.94K
195%
75 decisions on file.